Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 14.527\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a O=C(CSc1nc2ncc(Cl)cc2[nH]1)NC1CCS(=O)(=O)C1
b Cc1cc(SCC(=O)Nc2ccc(O)cc2)n2ncc(-c3ccccc3)c2n1
c CSc1cnn(Cc2ccccc2)c(=O)c1SCc1ccccc1
Answer: b. Cc1cc(SCC(=O)Nc2ccc(O)cc2)n2ncc(-c3ccccc3)c2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(SCC(=O)Nc2ccc(O)cc2)n2ncc(-c3ccccc3)c2n1
Cc1cc(SCC(=O)Nc2ccc(O)cc2)n2ncc(-c3ccccc3)c2n1
N-(4-hydroxyphenyl)-2-(5-methyl-3-phenylpyrazolo[1,5-a]pyrimidin-7-yl)sulfanylacetamide